These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10817746)

  • 61. CDR4 is the major contributor to azole resistance among four Pdr5p-like ABC transporters in Neurospora crassa.
    Zhang Y; Zhang Z; Zhang X; Zhang H; Sun X; Hu C; Li S
    Fungal Biol; 2012 Jul; 116(7):848-54. PubMed ID: 22749171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of uridine 5'-eicosylphosphate as a stimulant of cyclic AMP-dependent cellular function.
    Yutani M; Ogita A; Fujita K; Usuki Y; Tanaka T
    Gen Physiol Biophys; 2011 Mar; 30(1):106-9. PubMed ID: 21460419
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quaternary ammonium salt-resistant mutants in yeast Saccharomyces cerevisiae.
    Obłak E; Ułaszewski S; Morawiecki A; Witek S; Witkowska R; Majcher K; Lachowicz TM
    Yeast; 1989 Apr; 5 Spec No():S273-7. PubMed ID: 2665361
    [No Abstract]   [Full Text] [Related]  

  • 65. Structural and functional study of YER067W, a new protein involved in yeast metabolism control and drug resistance.
    Domitrovic T; Kozlov G; Freire JC; Masuda CA; da Silva Almeida M; Montero-Lomeli M; Atella GC; Matta-Camacho E; Gehring K; Kurtenbach E
    PLoS One; 2010 Jun; 5(6):e11163. PubMed ID: 20567505
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid determination of antifungal activity by flow cytometry.
    Green L; Petersen B; Steimel L; Haeber P; Current W
    J Clin Microbiol; 1994 Apr; 32(4):1088-91. PubMed ID: 8027319
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem.
    Kelly SL; Lamb DC; Kelly DE
    FEMS Microbiol Lett; 1999 Nov; 180(2):171-5. PubMed ID: 10556708
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Evaluation of a breakpoint test for determination of fluconazole susceptibility of yeasts].
    Fegeler W
    Mycoses; 1997; 40 Suppl 1():47-52. PubMed ID: 9417513
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
    Vermitsky JP; Edlind TD
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance.
    Keniya MV; Fleischer E; Klinger A; Cannon RD; Monk BC
    PLoS One; 2015; 10(5):e0126350. PubMed ID: 25951180
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux.
    Golin J; Ambudkar SV; Gottesman MM; Habib AD; Sczepanski J; Ziccardi W; May L
    J Biol Chem; 2003 Feb; 278(8):5963-9. PubMed ID: 12496287
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The unusual inheritance of multidrug-resistance factors in Saccharomyces.
    Shallom JM; Golin J
    Curr Genet; 1996 Aug; 30(3):212-7. PubMed ID: 8753649
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Antifungal susceptibility of emerging yeast pathogens].
    García-Martos P; Domínguez I; Marín P; García-Agudo R; Aoufi S; Mira J
    Enferm Infecc Microbiol Clin; 2001; 19(6):249-56. PubMed ID: 11440661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.
    Moran G; Sullivan D; Morschhäuser J; Coleman D
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2829-41. PubMed ID: 12183235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genomic and transcriptome identification of fluconazole-resistant genes for Trichosporon asahii.
    Xia Z; Yu H; Wang C; Ding X; Zhang D; Tan X; Chen J; Hu S; Yang R
    Med Mycol; 2020 Apr; 58(3):393-400. PubMed ID: 31504756
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Control of nongenetic heterogeneity in growth rate and stress tolerance of Saccharomyces cerevisiae by cyclic AMP-regulated transcription factors.
    Li S; Giardina DM; Siegal ML
    PLoS Genet; 2018 Nov; 14(11):e1007744. PubMed ID: 30388117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.